The new melanoma markers: MART-1 and melan-A (the NIH experience)

被引：36

作者：

Fetsch, PA ^{[1
]}

Marincola, FM

Abati, A

机构：

[1] NCI, Cytopathol Sect, NIH, Bethesda, MD 20892 USA

[2] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA

来源：

AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 1999年 / 23卷 / 05期

关键词：

D O I：

10.1097/00000478-199905000-00017

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：607 / 609

页数：3

共 27 条

[1]

Beaty MW, 1997, CANCER CYTOPATHOL, V81, P57, DOI 10.1002/(SICI)1097-0142(19970225)81:1<57::AID-CNCR12>3.0.CO

[2]

2-B

[3] Immunoreactivity for A103, an antibody to Melan-A (MART-1), in adrenocortical and other steroid tumors [J].

Busam, KJ ;

Iversen, K ;

Coplan, KA ;

Old, LJ ;

Stockert, E ;

Chen, YT ;

McGregor, D ;

Jungbluth, A .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (01) :57-63

[4]

Busam KJ, 1998, MODERN PATHOL, V11, p47A

[5] Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas [J].

Chen, YT ;

Stockert, E ;

Jungbluth, A ;

Tsang, SL ;

Coplan, KA ;

Scanlan, MJ ;

Old, LJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5915-5919

[6] Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: Implications for immunotherapy [J].

Cormier, JN ;

Abati, A ;

Fetsch, P ;

Hijazi, YM ;

Rosenberg, SA ;

Marincola, FM ;

Topalian, SL .

JOURNAL OF IMMUNOTHERAPY, 1998, 21 (01) :27-31

[7]

Cormier JN, 1998, INT J CANCER, V75, P517, DOI 10.1002/(SICI)1097-0215(19980209)75:4<517::AID-IJC5>3.0.CO

[8]

2-W

[9] A NEW GENE CODING FOR A DIFFERENTIATION ANTIGEN RECOGNIZED BY AUTOLOGOUS CYTOLYTIC T-LYMPHOCYTES ON HLA-A2 MELANOMAS [J].

COULIE, PG ;

BRICHARD, V ;

VANPEL, A ;

WOLFEL, T ;

SCHNEIDER, J ;

TRAVERSARI, C ;

MATTEI, S ;

DEPLAEN, E ;

LURQUIN, C ;

SZIKORA, JP ;

RENAULD, JC ;

BOON, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :35-42

[10]

FETSCH P, IN PRESS MOD PATHOL

← 1 2 3 →